eXoZymes, Inc. (EXOZ)
NASDAQ: EXOZ · Real-Time Price · USD
7.90
-0.52 (-6.18%)
At close: Jun 30, 2026, 4:00 PM EDT
8.43
+0.53 (6.71%)
After-hours: Jun 30, 2026, 4:10 PM EDT
eXoZymes Market Cap
eXoZymes has a market cap or net worth of $66.98 million as of June 30, 2026. Its market cap has decreased by -40.94% in one year.
Market Cap
66.98M
Enterprise Value
71.37M
1-Year Change
-40.94%
Ranking
Category
Stock Price
$7.90
Market Cap Chart
Since November 13, 2024, eXoZymes's market cap has decreased from $70.30M to $66.98M, a decrease of -4.72%. That is a compound annual growth rate of -2.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 66.98M | -26.73% |
| Dec 31, 2025 | 91.42M | -41.85% |
| Dec 31, 2024 | 157.23M | 123.64% |
| Nov 13, 2024 | 70.30M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elicio Therapeutics | 76.29M |
| Acrivon Therapeutics | 76.19M |
| Seres Therapeutics | 74.66M |
| Cingulate | 71.66M |
| BeyondSpring | 71.14M |
| XBiotech | 71.04M |
| Pliant Therapeutics | 70.97M |
| PMV Pharmaceuticals | 68.80M |